Abstract
Human induced pluripotent stem cells (hiPSCs) can be used to generate various cell types in the human body. Hence, hiPSC-derived cardiomyocytes (hiPSC-CMs) represent a significant cell source for disease modeling, drug testing, and regenerative medicine. The immaturity of hiPSC-CMs in two-dimensional (2D) culture limit their applications. Cardiac tissue engineering provides a new promise for both basic and clinical research. Advanced bioengineered cardiac in vitro models can create contractile structures that serve as exquisite in vitro heart microtissues for drug testing and disease modeling, thereby promoting the identification of better treatments for cardiovascular disorders. In this review, we will introduce recent advances of bioengineering technologies to produce in vitro cardiac tissues derived from hiPSCs.
| Original language | English (US) |
|---|---|
| Article number | 168 |
| Journal | Bioengineering |
| Volume | 9 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 3D bioprinting
- 3D models
- CPVT
- ECM
- Layer-by-Layer
- cardiac organoid
- cardiac tissue engineering
- cardiomyocytes
- differentiation
- disease modeling
- drug development
- drug screening
- heart-on-a-chip
- hiPSC-CMs
- human induced pluripotent stem cell
- iPSC
- maturation
ASJC Scopus subject areas
- Bioengineering
Fingerprint
Dive into the research topics of 'Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS